EFFECTS OF NOVEL CORONAVIRUS DISEASE-19 (COVID-19) ON VITAL ORGANS IN PATIENTS INFECTED WITH SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 (SARS-COV-2)

2021 ◽  
Author(s):  
M. Ibrahim Hossain ◽  
Esha Binte Shahriar ◽  
Anamika Sarker ◽  
Nafisa Lubna ◽  
Mehjabeen Haque ◽  
...  
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
Peer Review ◽  
Cell Surface Receptor ◽  
World Health ◽  
Health Concern ◽  
The World ◽  
Surface Receptor ◽  
Review Reports ◽  
Novel Coronavirus ◽  
Health Organization

The world is now facing one of the most devastating public health concern where the 2019 novel coronavirus (2019-nCoV) or the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection is spreading all over the world initiating from Wuhan, China, started from December, 2019. The World Health Organization (WHO) already announced the situation as pandemic all over the world. According to the webpage of WHO, this SARS-CoV-2 has been spreading all over the world (223 countries, areas or territories) with 126,890,643 of confirmed cases and 2,778,619 of confirmed deaths(as time of March 30, 2021). Accumulated published documents indicate that the SARS-CoV-2 virus primarily affects the lungs causing hypoxia which is the leading cause of death. There are many reports describing that with the progress of this disease, many other organs (such as heart, kidney, liver, brain) of the affected person start to malfunction. Though SARS-CoV-2 uses the cell surface receptor angiotensin-converting enzyme 2 (ACE-2) expressed by lungs, cardiovascular system, kidneys but it is still not clear except lungs all these other organs are directly affected by this virus or not. Therefore, the aim of this review is to gather information about the affected/damaged organs or tissues and the consequences of this damage in the COVID-19 patients.                    Peer Review History: Received 11 March 2021; Revised 8 April; Accepted 23 April, Available online 15 May 2021 UJPR follows the most transparent and toughest ‘Advanced OPEN peer review’ system. The identity of the authors and, reviewers will be known to each other. This transparent process will help to eradicate any possible malicious/purposeful interference by any person (publishing staff, reviewer, editor, author, etc) during peer review. As a result of this unique system, all reviewers will get their due recognition and respect, once their names are published in the papers. We expect that, by publishing peer review reports with published papers, will be helpful to many authors for drafting their article according to the specifications. Auhors will remove any error of their article and they will improve their article(s) according to the previous reports displayed with published article(s). The main purpose of it is ‘to improve the quality of a candidate manuscript’. Our reviewers check the ‘strength and weakness of a manuscript honestly’. There will increase in the perfection, and transparency.  Received file:                Reviewer's Comments: Average Peer review marks at initial stage: 6.0/10 Average Peer review marks at publication stage: 7.0/10 Reviewer(s) detail: Dr. Vanina Doris Edo’o, University of Yaounde I, Yaounde, Cameroun, [email protected] Idoko Alexander, Caritas University, Enugu, Nigeria, [email protected] Similar Articles: COVID-19: PHARMACOLOGICAL AND THERAPEUTIC APPROACHES USE OF COLCHICINE TO COUNTERACT THE STRONG HYPERINFLAMMATORY STATE INDUCED BY SARS-COV-2 THE RISKS AND ADVANTAGES OF ANTI-DIABETES THERAPY IN THE POSITIVE COVID-19 PATIENT

Aftermath of Covid -19 Pandemic in the community

2021 ◽  
pp. 498-500
Author(s):  
Sholly. CK
Keyword(s):  
World Health Organization ◽  
Antiviral Treatment ◽  
World Health ◽  
Health Concern ◽  
Severe Illness ◽  
Respiratory Illnesses ◽  
The World ◽  
Novel Coronavirus ◽  
Health Organization ◽  
Respiratory Droplets

Novel corona virus (COVID-19) is an infectious condition, which can be spread directly or indirectly from one person to another and causes respiratory illnesses, range from common cold to acute respiratory syndrome. The first cases of this virus were found in Wuhan, China. According to the World Health Organization, COVID-19 is serious health concern and has higher risk for severe illness and spreading rapidly all over the world.This novel coronavirus was named Coronavirus Disease 2019 (COVID-19) by WHO in February 2020. The World Health Organization (WHO) has declared the coronavirus disease 2019 a pandemic, in the year2020 March. A global coordinated effort is needed to stop the further spread of the virus. Among all cases about 92% of the confirmed cases were recorded from China. Initial reports suggest that death rate ranges from 1% to 2% which varies in the study and country. The most of the death have occurred in patients over 50 years of age followed by young children. For the confirmed cases which included both laboratory and clinically diagnosed till now there is no specific antiviral treatment recommended but there is vaccine currently available. Once the virus develops in people, corona viruses can be spread from person to person through respiratory droplets. The viral material hangs out in these droplets and can be breathed into the respiratory tract, where the virus can then lead to an infection. Repercussions of Covid -19 on individuals, families and on front line warriors are countless1.

scholarly journals A comparison of COVID-19, SARS and MERS

PeerJ ◽  
2020 ◽  
Vol 8 ◽  
pp. e9725 ◽  
Author(s):  
Tingting Hu ◽  
Ying Liu ◽  
Mingyi Zhao ◽  
Quan Zhuang ◽  
Linyong Xu ◽  
...  
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
Case Fatality ◽  
Hubei Province ◽  
World Health ◽  
Atypical Pneumonia ◽  
Organization Studies ◽  
Optimal Method ◽  
The World ◽  
Novel Coronavirus ◽  
Health Organization

In mid-December 2019, a novel atypical pneumonia broke out in Wuhan, Hubei Province, China and was caused by a newly identified coronavirus, initially termed 2019 Novel Coronavirus and subsequently severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As of 19 May 2020, a total of 4,731,458 individuals were reported as infected with SARS-CoV-2 among 213 countries, areas or territories with recorded cases, and the overall case-fatality rate was 6.6% (316,169 deaths among 4,731,458 recorded cases), according to the World Health Organization. Studies have shown that SARS-CoV-2 is notably similar to (severe acute respiratory syndrome coronavirus) SARS-CoV that emerged in 2002–2003 and Middle East respiratory syndrome coronavirus (MERS-CoV) that spread during 2012, and these viruses all contributed to global pandemics. The ability of SARS-CoV-2 to rapidly spread a pneumonia-like disease from Hubei Province, China, throughout the world has provoked widespread concern. The main symptoms of coronavirus disease 2019 (COVID-19) include fever, cough, myalgia, fatigue and lower respiratory signs. At present, nucleic acid tests are widely recommended as the optimal method for detecting SARS-CoV-2. However, obstacles remain, including the global shortage of testing kits and the presentation of false negatives. Experts suggest that almost everyone in China is susceptible to SARS-CoV-2 infection, and to date, there are no effective treatments. In light of the references published, this review demonstrates the biological features, spread, diagnosis and treatment of SARS-CoV-2 as a whole and aims to analyse the similarities and differences among SARS-CoV-2, SARS-CoV and MERS-CoV to provide new ideas and suggestions for prevention, diagnosis and clinical treatment.

scholarly journals Venous Thromboembolism and Its Association with COVID-19: Still an Open Debate

Medicina ◽  
2020 ◽  
Vol 56 (10) ◽  
pp. 506 ◽  
Author(s):  
Pierpaolo Di Micco ◽  
Vincenzo Russo ◽  
Corrado Lodigiani
Keyword(s):  
Venous Thromboembolism ◽  
Severe Acute Respiratory Syndrome ◽  
World Health ◽  
Diagnostic Tools ◽  
Unknown Etiology ◽  
The World ◽  
Open Debate ◽  
Novel Coronavirus ◽  
Health Organization ◽  
Pharmacological Thromboprophylaxis

Asreported by the World Health Organization, a novel coronavirus (COVID-19) was identified as the causative virus of new viral pneumonia of unknown etiology by Chinese authorities on 7 January 2020. The virus was named COVID-19 and because of its ability to cause severe acute respiratory syndrome (i.e., SARS) this infection has also been defined as SARS-CoV2.Furthermore, an association between COVID-19 infection and venous thromboembolism has been reported in several series around the world.For this reason, methods used to improve diagnostic tools, pharmacological thromboprophylaxis and type of anticoagulants are discussed in this expert opinion.

scholarly journals SARS update 11 April - Compelling evidence for aetiology, WHO team report from China, global epidemiology, and EU index and guidance

2003 ◽  
Vol 7 (15) ◽  
Author(s):  
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
World Health Organization ◽  
Online Publication ◽  
World Health ◽  
Compelling Evidence ◽  
Interim Report ◽  
Global Epidemiology ◽  
The World ◽  
Novel Coronavirus ◽  
Health Organization

Several articles on the identification of a novel coronavirus thought to have a role in causing severe acute respiratory syndrome (SARS) have been given early online publication this week (1-5), and the World Health Organization (WHO) has published an interim report from the WHO team of experts currently investigating the outbreak in China (7).

scholarly journals COVID-19 Mimicking Acute Colitis

2021 ◽  
Vol 96 (2) ◽  
pp. 143-146
Author(s):  
Jaeseok Park ◽  
Jaekwon Jung ◽  
Hyunsoo Kim ◽  
Changkeun Park ◽  
Daejin Kim ◽  
...  
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
World Health Organization ◽  
Clinical Picture ◽  
Hubei Province ◽  
World Health ◽  
Acute Colitis ◽  
The World ◽  
The Common ◽  
Novel Coronavirus ◽  
Health Organization

On 11 February, 2020, the World Health Organization announced that COVID-19 was a novel coronavirus disease first detected in Wuhan, Hubei Province, China. COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The complete clinical picture is not fully known. Illness ranges from mild to fatal. The common symptoms include fever, cough, and dyspnea usually developing 2-14 days after exposure. However, diarrhea was present in a few patients with COVID-19. We report a case of COVID-19 mimicking acute colitis.

scholarly journals Oral medicine, oral pathology and coronavirus (2019-nCoV)

2020 ◽  
Vol 19 ◽  
pp. e200001
Author(s):  
Hercílio Martelli-Júnior ◽  
Renato Assis Machado ◽  
Daniella R. Barbosa Martelli ◽  
Ricardo Della Coletta
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
World Health Organization ◽  
Causative Agent ◽  
Oral Pathology ◽  
World Health ◽  
Oral Medicine ◽  
The World ◽  
Novel Coronavirus ◽  
Health Organization

In late December 2019, a cluster of unexplained pneumonia cases was diagnosed in Wuhan, China, and few days later, the causative agent of this mysterious pneumonia was identified as a novel coronavirus. This causative virus has been temporarily named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the relevant infected disease has been named as coronavirus disease 2019 (COVID-19) by the World Health Organization respectively. The COVID-19 epidemic is spreading in China and all over the world now...

scholarly journals Principles of Care for Patients with Liver Disease During the Coronavirus Disease 2019 (COVID-19) Pandemic: Position Statement of the Saudi Association for the Study of Liver Disease and Transplantation

2020 ◽  
Vol 40 (4) ◽  
pp. 273-280 ◽  
Author(s):  
Saleh A. Alqahtani ◽  
Abdulrahman A. Aljumah ◽  
Almoutaz Hashim ◽  
Thamer H. Alenazi ◽  
Mohammed AlJawad ◽  
...  
Keyword(s):  
Older Adults ◽  
Liver Disease ◽  
Severe Acute Respiratory Syndrome ◽  
Position Statement ◽  
World Health ◽  
Global Pandemic ◽  
Regular Care ◽  
The World ◽  
Novel Coronavirus ◽  
Health Organization

ABSTRACT In December 2019, a novel coronavirus was identified in patients in Wuhan, China. The virus, subsequently named severe acute respiratory syndrome coronavirus-2, spread worldwide and the disease (coronavirus disease 2019 or COVID-19) was declared a global pandemic by the World Health Organization in March 2020. Older adults and individuals with comorbidities have been reported as being more vulnerable to COVID-19. Patients with chronic liver disease (CLD) have compromised immune function due to cirrhosis and are more susceptible to infection. However, it is unclear if patients with CLD are more vulnerable to COVID-19 and its complications than other populations. The high number of severe cases of COVID-19 has placed an unusual burden on health systems, compromising their capacity to provide the regular care that patients with CLD require. Hence, it is incredibly crucial at this juncture to provide a set of interim recommendations on the management of patients with CLD during the current COVID-19 outbreak.

COVID-19 in Immunocompromised Patients: A Systematic Review

2021 ◽  
Vol 42 (06) ◽  
pp. 839-858
Author(s):  
Anna Stainer ◽  
Francesco Amati ◽  
Giulia Suigo ◽  
Edoardo Simonetta ◽  
Andrea Gramegna ◽  
...  
Keyword(s):  
Systematic Review ◽  
Severe Acute Respiratory Syndrome ◽  
Central China ◽  
World Health ◽  
Immunocompromised Patients ◽  
The World ◽  
Different Types ◽  
Novel Coronavirus ◽  
Health Organization ◽  
Present Systematic Review

AbstractSevere acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was first identified as a novel coronavirus in Wuhan, Hubei province, central China, in December 2019, and is responsible for the 2019-to-present pandemic. According to the most recent data released by the World Health Organization, more than 200 million people have been infected by SARS-CoV-2 so far, and more than 4 million people died worldwide. Although our knowledge on SARS-CoV-2 and COVID-19 is constantly growing, data on COVID-19 in immunocompromised patients are still limited. The aim of the present systematic review is to describe clinical picture, disease severity, proposed treatment regimen, and response to vaccination in patients with different types and severity of immunosuppression.

scholarly journals Dampak pandemi coronavirus disease 2019 terhadap kualitas publikasi ilmiah

2021 ◽  
Vol 4 (1) ◽  
pp. 1-4
Author(s):  
Yenny Yenny
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
World Health Organization ◽  
World Health ◽  
The World ◽  
Novel Coronavirus ◽  
Health Organization

Dunia medis belakangan ini digemparkan dengan dilaporkan adanya temuan kasus pneumonia tipe baru di kota Wuhan, Provinsi Hubei, Cina pada akhir Desember 2019.(1)Belakangan diketahui bahwapenyakit pneumonia tersebut disebabkanoleh patogen varian baru coronavirus yang disebut sebagai  2019-novel coronavirus (2019-nCoV)/severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) yang selanjutnya dikenal sebagai coronavirus disease 2019 (COVID-19)dan oleh the World Health Organization dinyatakan sebagai pandemi global pada tanggal 11 Maret 2020.(2)Semenjak itupara ilmuan mulai memfokuskan penelitian yang dilakukan pada topikyang berkaitan dengan COVID-19. Kondisi ini juga membawa dampak terdapatnya peningkatan volume publikasi artikel tentang COVID-19 yang sangat mencolok di mana dalam 6 bulan sejak terjadinya pandemi jumlah publikasi  berbentuk riset, letters, reviews, notes, dan editorial yang berhubungan dengan COVID-19 dilaporkan berjumlah lebih dari 23.500 artikel.(3)

scholarly journals Monkey experiments provide confirmation that a novel coronavirus is the cause of severe acute respiratory syndrome (SARS)

2003 ◽  
Vol 7 (16) ◽  
Author(s):  
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
World Health Organization ◽  
Diagnostic Test ◽  
World Health ◽  
Laboratory Network ◽  
The World ◽  
Expert Meeting ◽  
Novel Coronavirus ◽  
Health Organization

The World Health Organization (WHO) has formally announced that a member of the coronavirus family never before seen in humans, named by WHO and its SARS laboratory network as the SARS virus, is the cause of severe acute respiratory syndrome (SARS) (1). An expert meeting in Geneva, attended by representatives from the SARS laboratory network, reviewed the data available on SARS, and considered the imminent strategy for development of a diagnostic test for SARS.

Sign in / Sign up

Export Citation Format

Share Document